Applied DNA Sciences submits validation package to NYSDOH for bird flu test
Applied DNA Clinical Labs has submitted a validation package to the New York State Department of Health to request ...
Naveris Introduces Advanced NavDx+Gyn™ Test for Early Detection of HPV-Driven Gynecologic Cancers
Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the analytical validation of NavDx+Gyn, an important extension of the NavDx® blood test.
Refined test could improve Parkinson's disease diagnosis
A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from ...
360Dx15h
Invivoscribe Acute Myeloid Leukemia Assay Nabs Regulatory Compliance in UK, Switzerland
NEW YORK – Invivoscribe announced Thursday that its test for FLT3 mutations in patients with leukemia has achieved regulatory compliance in the UK and Switzerland.
Precision Medicine Online1d
Reveal Genomics' HER2DX Assay De-Escalates Early Breast Cancer Treatment in Real-World Study
The observational study measured how physicians changed treatment plans after seeing HER2DX results and how patients did on the new plans.
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
STONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader ...
LifeTracDx® Blood Test to be Performed in Key Colorectal Clinical Trial
Creatv Bio, a Division of Creatv MicroTech, Inc. (Creatv) will be collaborating with CytoDyn Therapeutics Corporation (CytoDyn) to assess patient response to their drug using the LifeTracDx® blood ...